Blue-Gray Discoloration of the Skin After Levofloxacin Exposure in a 44-Year-Old Man With Pulmonary Tuberculosis

    May 2023 in “ Authorea (Authorea) ”
    Babak Sayad, Zahra Fatahi, Dena Mohamadzadeh

    Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

    Studysummary In this report, researchers documented a rare complication linked to levofloxacin, used as a second-line treatment for tuberculosis, which could include various adverse events during TB therapy.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on authorea.com →
    Discuss this study in the Community →